Drug Cos. Say 'Buy US' Order Would Hurt COVID-19 Response
Generic-drug makers are sounding the alarm over an anticipated "Buy American" executive order, saying that forcing federal agencies to buy U.S.-made drugs and medical supplies will disrupt pharmaceutical supply chains already...To view the full article, register now.
Already a subscriber? Click here to view full article